Phase I clinical trial using peptide vaccine for human vascular endothelia 1 growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer.

Bibliographic Information

Title
Phase I clinical trial using peptide vaccine for human vascular endothelia 1 growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer.
Author
Miyazawa M

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010000782090552960
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top